News

Shields recently worked as a CEO of Artromick International, a developer of healthcare technology for acute and long-term care markets. Prior to Artromick, he was senior vice president

The study will focus initially on the safety and tolerability of IQNLF, one component of IQ-DAA. The study is being conducted by QPS Netherlands BV, and will initially

Omnicare offers clinical research services for the pharmaceutical and biotechnology industries. The company reported net loss was $65.29m, compared to a net income of $79.79m for the same

The two companies will provide over 10,000 cancer care professionals with early access to the latest panels of protein biomarkers implicated in different cancers. Avantra had announced the

Persistent’s PaxPro Brand Asset Lifecycle Management solution is a secure, policy-based solution designed to review and approve all media content within complex packaging and branding workflows. It offers

Modufolin is anticipated to increase the efficacy and reduce the side effects of cytotoxic pharmaceuticals. The approval allows Isofol Medical to start its first clinical trial on humans,

Under the agreement, JHP Pharma will be responsible for manufacturing and supply of an approved therapy used in cancer patients. JHP Pharma manufactures sterile injectables, biologics, vaccines, ophthalmics

ENB-0040 is a bone targeted enzyme replacement therapy designed to directly target TNSALP to the bone in order to correct the enzyme deficiency, which could result in restoration

Pfizer has already paid $200m to Biocon, as part of the agreement signed between them in October 2010, to get access to the supply of four generic insulin